Vijay K. Iyengar
CIK: 0001670000
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Sep 9, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
76.1K shares- - Jul 16, 2025INCY
INCYTE CORP
Sale(S)Direct983 shares at avg. $68.36$67K - Jul 15, 2025INCY
INCYTE CORP
Sale(S)Direct1.2K shares at avg. $69.86$82K - Jul 15, 2025INCY
INCYTE CORP
Award(A)Direct6.4K shares- - Jul 15, 2025INCY
INCYTE CORP
Tax Payment(F)Direct836 shares at avg. $68.25$57K - Jul 14, 2025INCY
INCYTE CORP
Tax Payment(F)Direct595 shares at avg. $69.98$42K - Jul 3, 2025INCY
INCYTE CORP
Sale(S)Direct2.7K shares at avg. $68.16$183K - Jul 3, 2025INCY
INCYTE CORP
Sale(S)Direct5.9K shares at avg. $68.15$404K - Jul 2, 2025INCY
INCYTE CORP
Tax Payment(F)Direct6.8K shares at avg. $68.17$464K - Apr 1, 2025INCY
INCYTE CORP
Award(A)Direct11.2K shares- - Apr 1, 2025INCY
INCYTE CORP
Award(A)Direct11K shares- - Jan 17, 2025INCY
INCYTE CORP
Award(A)DirectEmployee Stock Option (right to buy)
14.8K shares- - Nov 29, 2024INCY
INCYTE CORP
Sale(S)Direct360 shares at avg. $75.60$27K - Nov 29, 2024INCY
INCYTE CORP
Sale(S)Direct5.7K shares at avg. $75.37$428K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 9, 2026 |  WHWK Whitehawk Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 76,080 | - | - | Direct |
| Jul 16, 2025 |  INCY INCYTE CORP | Sale(S) | 983 | $68.36 | $67,198 | Direct |
| Jul 15, 2025 | INCY INCYTE CORP | Sale(S) | 1,177 | $69.86 | $82,225 | Direct |
| Jul 15, 2025 | INCY INCYTE CORP | Award(A) | 6,430 | - | - | Direct |
| Jul 15, 2025 | INCY INCYTE CORP | Tax Payment(F) | 836 | $68.25 | $57,057 | Direct |
| Jul 14, 2025 | INCY INCYTE CORP | Tax Payment(F) | 595 | $69.98 | $41,638 | Direct |
| Jul 3, 2025 | INCY INCYTE CORP | Sale(S) | 2,682 | $68.16 | $182,805 | Direct |
| Jul 3, 2025 | INCY INCYTE CORP | Sale(S) | 5,935 | $68.15 | $404,470 | Direct |
| Jul 2, 2025 | INCY INCYTE CORP | Tax Payment(F) | 6,809 | $68.17 | $464,170 | Direct |
| Apr 1, 2025 | INCY INCYTE CORP | Award(A) | 11,159 | - | - | Direct |
| Apr 1, 2025 | INCY INCYTE CORP | Award(A) | 10,982 | - | - | Direct |
| Jan 17, 2025 | INCY INCYTE CORP | Award(A) Employee Stock Option (right to buy) | 14,772 | - | - | Direct |
| Nov 29, 2024 | INCY INCYTE CORP | Sale(S) | 360 | $75.60 | $27,216 | Direct |
| Nov 29, 2024 | INCY INCYTE CORP | Sale(S) | 5,683 | $75.37 | $428,328 | Direct |
1-14 of 14 transactions
About Iyengar Vijay K
Iyengar Vijay K (SEC CIK 0001670000) files insider reports with the SEC as Director of Whitehawk Therapeutics, Inc. (WHWK) and EVP, GMAPPS of INCYTE CORP (INCY).
Signal8 holds 8 ownership filings by Iyengar Vijay K (1 Form 3, 7 Form 4), filed between Dec 3, 2024 and Sep 11, 2026. Those filings report 14 transactions, from Nov 29, 2024 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Iyengar Vijay K's filings is in MORRISTOWN, NJ.
Recent filings by Iyengar Vijay K
- Sep 9, 2026: Grant or award of WHWK derivative securities (Form 4, code A).
- Jul 16, 2025: Open-market sale of INCY shares (Form 4, code S).
- Jul 15, 2025: Open-market sale of INCY shares (Form 4, code S).
- Jul 15, 2025: Grant or award of INCY shares (Form 4, code A).
- Jul 15, 2025: Tax withholding of INCY shares (Form 4, code F).
Other insiders filing for Whitehawk Therapeutics, Inc. (WHWK)
- Giacobello Scott M., CHIEF FINANCIAL OFFICER
- BALL BRYAN
- Dornan David, Chief Scientific Officer
- Lennon David James, CHIEF EXECUTIVE OFFICER
- Dugan Margaret, Chief Medical Officer
- Dalal Anupam, Director